Impaired IFN-γ production of Vα24 NKT cells in non-remitting sarcoidosis

International Immunology

Volumn 16, Issue 2, 2004, Pages 215-222

  Kobayashi, Seiichiro ^a   Kaneko, Yoshikatsu ^a   Seino, Ken Ichiro ^b,c   Yamada, Yoshihito ^a   Motohashi, Shinichiro ^a   Koike, Junzo ^a   Sugaya, Kaoru ^a   Kuriyama, Takayuki ^a   Asano, Shigetaka ^d   Tsuda, Tomiyasu ^e   Wakao, Hiroshi ^b   Harada, Michishige ^b   Kojo, Satoshi ^b   Nakayama, Toshinori ^a   Taniguchi, Masaru ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OITA UNIVERSITY   (Japan)

Author keywords

Cytokine; Human; Inflammation; Lung; Th1 Th2 cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG SARCOIDOSIS; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TH1 CELL;

ADULT; AUTOIMMUNE DISEASES; FEMALE; FLOW CYTOMETRY; GRANULOMA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOIDOSIS, PULMONARY;

EID: 10744222573     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh020     Document Type: Article

References (28)

1. α14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.
2. - T cells. J. Exp. Med. 180:1171.
3. α genes and an invariant TCR α chain. J. Exp. Med. 178:1.
4. α14 NKT cells by glycosylceramides. Science 278:1626.
5. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307.
6. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
7. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
8. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J. F. and Herbelin, A. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7:1057.
9. Seino, K., Fulkao, K., Muramoto, K., Yanagisawa, K., Takada, Y., Kakuta, S., Iwakura, Y., Van Kaer, L., Takeda, K., Nakayama, T., Taniguchi, M., Bashuda, H., Yagita, H. and Okumura, K. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl Acad. Sci. USA 98:2577.
10. α14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105:1761.
11. Apostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournie, J. J., Kourilsky, P. and Gachelin, G, 1999. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl Acad. Sci. USA 96:5141.
12. Newman, L. S., Rose, C. S. and Maier, L. A. 1997. Sarcoidosis. N. Engl. J, Med, 336:1224.
13. Ishige, I., Usul, Y., Takemura, T. and Eishi, Y. 1999. Quantitative PCR of mycobacterial and prop ioni bacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354:120.
14. h1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156:4952.
15. O'Regan, A. W., Chupp, G. L., Lowry, J. A., Goetschkes, M., Mulligan, N. and Berman, J. S. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytolkine-like properties in vitro. J. Immunol. 162:1024.
16. h2 cell distribution in pulmonary sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 16:171.
17. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 160:736.
18. Consensus Conference: Activity of Sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur. Respir. J. 7:624.
19. α24 NKT cells. Cancer Res. 59:5102.
20. Yamashita, M., Kimura, M., Kubo, M., Shimizu, C., Tada, T., Perlmutter, R. M. and Nakayama, T. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl Acad. Sci. USA 96:1024.
21. α14 NKT cells. Proc. Natl Acad. Sci. USA 95:5690.
22. + DN T cells. Microbiol. Immunol. 43:577.
23. + NK T cells in the early stages of embryogenesis. Proc. Natl Acad. Sci. USA 93:6516.
24. Agostini, C., Meneghin, A, and Semenzato, G. 2002. T-lymphocytes and cytokines in sarcoidosis. Curr. Opin. Pulm. Med. 8:435.
25. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med.187:1047.
26. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S., Sriram, S., Koezuka, Y. and Van Kaer, L. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
27. α14 natural killer T cells. J. Exp. Med. 190:783.
28. α repertoire. Am. J. Pathol. 157:509.